VCN Biosciences Alternatives & Competitors

12 companies similar to VCN Biosciences — Pioneering advanced tumor treatments through innovative oncolytic virus technolo...

VYROBIO

Developing next-generation viral immunotherapies to treat aggressive, fast-growing forms o...

9 Seed $1.50M

Brazil

Biotechnology

Immupeutics Medicine

Advancing the future of tumor treatment through innovative research and application in imm...

11-50 Seed $100.00M

Biotechnology

Huasaiboman Medical Cell Biology

Pioneering tomorrow's treatments for solid tumors and degenerative diseases through state-...

Series A

Biotechnology Life Sciences +1

OncoMyx Therapeutics

We are developing myxoma virotherapies to expand the effectiveness of immunotherapies in t...

8 Series B $75.00M

Phoenix, United States

Biotechnology Health Care +1

Track all VCN Biosciences competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Farcast Biosciences

24,000 human tumors and counting - building the most precise functional precision tumor mi...

38 Pre-Seed $74.63M

Bengaluru, India

Biotechnology Health Care +1

Codagenix Inc.

Design Platform for Vaccine & Oncolytic Virus development ~ COVID, Flu, RSV, Dengue, YF /...

19 Grant $65.60M

Farmingdale, United State...

Biotechnology

Genelux

34 Post-IPO Equity $98.98M

Westlake Village, United...

Biopharma Biotechnology +1

VacV Biotherapeutics

Developing oncolytic viruses as therapeutics for cancer

6 Seed $3.00M

London, United Kingdom

Biotechnology Health Care +1

cTRL Therapeutics

We are simplifying solid tumor cell therapy to unlock the next frontier of cancer therapie...

9 Seed $10.00M

San Francisco, United Sta...

Biotechnology Health Care +2

Abdera Therapeutics

36 Series B $150.00M

South San Francisco, Unit...

Biotechnology Health Care +1

Theolytics

Transforming patients’ lives | Through world leading science | With a great team

31 Venture round $50.40M

Oxford, United Kingdom

Biotechnology Health and Wellness

Tyrogenex

Innovative biotech solutions for solid tumors through advanced multi-kinase angiogenesis i...

Venture round $21.40M

Biotechnology Health and Wellness +1

About VCN Biosciences

VCN Biosciences is a biotechnology startup founded in 2009 with a focus on pioneering advanced tumor treatments. The company specializes in the research and development of new treatments for tumors, utilizing oncolytic virus technology. In July 2012, VCN Biosciences secured its last investment in a funding round led by...

Business keywords

Oncolytic Virus, Tumor Treatment, VCN Biosciences, Innovative Technology, Research And Development, Advanced Therapy, Biosciences, Cancer Treatment, Medical Innovation, Cancer Research

Frequently Asked Questions

Companies similar to VCN Biosciences include VYROBIO, Immupeutics Medicine, Huasaiboman Medical Cell Biology, OncoMyx Therapeutics, Farcast Biosciences. They work in Biotechnology and share VCN Biosciences's focus on cancer treatment, oncolytic virus and cancer research.

Bounce Watch lists 12 companies that share VCN Biosciences's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches VCN Biosciences and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

VCN Biosciences Profile VYROBIO Alternatives Immupeutics Medicine Alternatives Huasaiboman Medical Cell Biology Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at VCN Biosciences on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.